# Gene Expression Analysis of HPRT-Deficient Cells Maintained with Physiological Levels of Folic Acid

**Authors:** Rosa J. Torres, Gerard Valentines-Casas, Claudia Cano-Estrada, Neus Ontiveros, José M. López

PMC · DOI: 10.3390/cells14141105 · 2025-07-18

## TL;DR

This study investigates how HPRT deficiency affects gene expression in human cells during neural development using physiological folic acid levels.

## Contribution

The study introduces a novel HPRT-deficient cell model and examines gene expression changes under physiological folate conditions.

## Key findings

- HPRT-deficient cells showed altered expression of pluripotency and homeobox genes.
- Neuroectodermal differentiation was possible but with dysregulated homeobox genes like EN1 and LMX1A.
- Gene ontology analysis linked HPRT deficiency to disrupted development and nervous system processes.

## Abstract

Lesch–Nyhan disease (LND) is associated with a complete deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT) activity due to mutations in the HPRT1 gene. Although the physiopathology of LND-related neurological manifestations remains unknown, a defective neuronal developmental process is the most widely accepted hypothesis. We generated an HPRT-deficient line from the pluripotent human embryonic cell line NT2/D1 by CRISPR-Cas9 and induced its differentiation along neuroectodermal lineages by retinoic acid treatment. As levels of folic acid in the culture media may affect results in LND models, we employed physiological levels of folate. The effect of HPRT deficiency on neural development-related gene expression was evaluated using two methodological approaches: a directed qPCR array of genes related to neuronal differentiation, and global gene expression by RNAseq. HPRT-deficient pluripotent cells presented altered expression of genes related to pluripotency in human embryonic stem cells, such as DPPA3 and CFAP95, along with genes of the homeobox gene family. HPRT-deficient pluripotent cells were able to differentiate along neuro-ectodermal lineages but presented consistent dysregulation of several genes from the homeobox gene family, including EN1 and LMX1A. GO enrichment analysis of up- and downregulated genes in HPRT-deficient cells showed that the most significant biological processes affected are related to development and nervous system development.

## Linked entities

- **Genes:** HPRT1 (hypoxanthine phosphoribosyltransferase 1) [NCBI Gene 3251], DPPA3 (developmental pluripotency associated 3) [NCBI Gene 359787], CFAP95 (cilia and flagella associated protein 95) [NCBI Gene 138255], EN1 (engrailed homeobox 1) [NCBI Gene 2019], LMX1A (LIM homeobox transcription factor 1 alpha) [NCBI Gene 4009]
- **Proteins:** HGPT (Hypoxanthine-guanine phosphoribosyltransferase)
- **Chemicals:** folic acid (PubChem CID 135398658), retinoic acid (PubChem CID 444795)
- **Diseases:** Lesch–Nyhan disease (MONDO:0010298)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** EN1 (engrailed homeobox 1) [NCBI Gene 2019] {aka ENDOVESLB}, DPPA3 (developmental pluripotency associated 3) [NCBI Gene 359787] {aka Pgc7, STELLA}, HPRT1 (hypoxanthine phosphoribosyltransferase 1) [NCBI Gene 3251] {aka HGPRT, HPRT}, LMX1A (LIM homeobox transcription factor 1 alpha) [NCBI Gene 4009] {aka DFNA7, LMX1, LMX1.1}
- **Diseases:** HPRT (MESH:D007926)
- **Chemicals:** retinoic acid (MESH:D014212), Folic Acid (MESH:D005492)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** NT2/D1 — Homo sapiens (Human), Embryonal carcinoma, Cancer cell line (CVCL_3407)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12293902/full.md

---
Source: https://tomesphere.com/paper/PMC12293902